JPRN-UMIN000004689已完成未知
Effect of DPP-4 inhibitor on beta cell protection - Effect of DPP-4 inhibitor on beta cell protection
Clinical Research Center,National Hospital Organization0 个研究点目标入组 1,200 人开始时间: 2010年12月9日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 1,200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients with type 1 diabetes mellitus 2)Patients who developed diabetic ketoacidosis,or diabetic pre-and coma within 24 weeks of the study entry. 3)Patients with severe infections or severe trauma or perioperative state. 4)Patients with renal insufficiency (CrCl=and>30mL/min, Serum creatinine=and>Male:1.5mg/dl,Female:1.3mg/dl) 5)Patients who received insulin therapy. 6) Patients with severe complication in cardiovascular system within 24 weeks before study entry. 7) Patients with pregnancy, possibility of pregnancy or having a breast feeding. 8)Patients who had a history of hypersensitive reaction to sitagliptin. 9)Patients who are deemed to be inappropriate by the investigator.
研究者
相似试验
已完成
不适用
Effects of dipeptidyl peptidase-4 (DPP-4) inhibitor, alogliptin, on coronary atherosclerosis in patients with type 2 diabetes mellitusPatients with type 2 diabetes mellitus who were suspected as having ischemic heart diseaseJPRN-UMIN000015381Kanagawa PTCA Conference50
招募中
不适用
Investigation of the impact of DPP-4 inhibition on serum brain natriuretic peptide level of diabetic patients with congestive heart failure.JPRN-UMIN000015685Mitsui Memorial Hospital50
已完成
不适用
Effect of DPP-4(dipeptidyl peptidase-4) inhibitor for coronary plaque in diabetes patients.JPRN-UMIN000007255Center for Cardiovascular Interventions,Chiba University Hospital128
尚未招募
不适用
The inhibitory effects of the DPP-4 inhibitor for progression of diabetic nephropathy, in the patients with type 2 diabetes in Japan.The CKD patients with type 2 diabetesJPRN-UMIN000011101Saitama Medical Center, Saitama Medical University50
已完成
不适用
The impact of dipeptidyl peptidase-4 inhibitor on coronary microvascular function in patients with type2 diabetes mellitusType 2 diabetic patients with stable angina pectoris who undergo percutaneous coronary interventionJPRN-UMIN000004390Cardiovascular Division, Hyogo College of Medicine40